血管造影衍生的血流储备分数指导经皮冠状动脉介入治疗
这项国际非劣效性试验随机分配1930例冠脉造影发现至少一处中间狭窄的患者,接受基于造影图像的FFRangio评估(965例)或压力导丝评估(965例)。主要终点为1年死亡、心肌梗死或非计划临床指征血运重建的复合终点。FFRangio组主要终点事件64例(Kaplan-Meier估计6.9%),压力导丝组65例(7.1%),风险比0.98(95%CI 0.70-1.39),差异-0.2个百分点,非劣效性P<0.001。两组出血、急性肾损伤或操作相关不良事件发生率无明显差异。
要点
- 在冠脉造影发现至少一处中间狭窄的患者中,FFRangio指导策略1年主要终点事件6.9%,压力导丝策略7.1%,风险比0.98(95%CI 0.70-1.39),非劣效性成立。
- 非劣效界值为3.5个百分点,差异-0.2个百分点,单侧97.5%CI上限为2.1个百分点。
- 两组出血、急性肾损伤或操作相关不良事件发生率无明显差异。
- FFRangio基于冠脉造影图像测量,与压力导丝FFR相关性良好,可能简化操作流程。
- 该策略适用于冠脉造影中发现中间冠状动脉狭窄并需生理学评估的患者。
适用人群与场景
- 接受冠状动脉造影、发现至少一处中间冠状动脉狭窄的患者。
- 研究纳入患者平均年龄68.4岁,女性占25.0%。
研究设计与关键结果
- 国际非劣效性试验,随机分配1930例患者至FFRangio组(965例)或压力导丝组(965例)。
- 主要终点为1年死亡、心肌梗死或非计划临床指征冠状动脉血运重建的复合终点。
- FFRangio组主要终点事件64例(Kaplan-Meier估计6.9%),压力导丝组65例(7.1%);风险比0.98(95%CI 0.70-1.39);差异-0.2个百分点;单侧97.5%CI上限2.1个百分点;非劣效性P<0.001。
- 两组出血、急性肾损伤或操作相关不良事件发生率无明显差异。
证据类型、等级与局限
- 证据类型:国际非劣效性随机对照试验。
- 非劣效界值为3.5个百分点。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于冠脉造影发现中间冠状动脉狭窄的患者,FFRangio指导的生理学评估策略可作为压力导丝策略的替代选择,因1年复合终点非劣效。
- FFRangio基于造影图像测量,可能简化生理学评估流程,但原文未报告对操作时间或辐射剂量的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI). However, clinical use of pressure-wire-based physiological assessment remains low. Measurement of fractional flow reserve (FFR) derived from coronary angiographic images alone correlates well with pressure-wire-based FFR measurements and may simplify procedures, but its effect on clinical outcomes is unknown.
METHODS: In this international noninferiority trial, we randomly assigned patients undergoing coronary angiography who were found to have at least one intermediate coronary stenosis to physiological assessment with measurements derived from angiographic images (FFRangio) or with pressure-wire-based measurements. The primary end point was a composite of death, myocardial infarction, or unplanned, clinically indicated coronary revascularization at 1 year. The noninferiority margin was 3.5 percentage points.
RESULTS: A total of 1930 patients were randomly assigned to physiological assessment with FFRangio (FFRangio group; 965 patients) or a pressure-wire-based approach (pressure-wire group; 965 patients). The mean age of the patients was 68.4 years, and 25.0% of the patients were women. At 1 year, a primary end-point event had occurred in 64 patients (Kaplan-Meier estimate, 6.9%) in the FFRangio group and 65 patients (Kaplan-Meier estimate, 7.1%) in the pressure-wire group (hazard ratio, 0.98; 95% confidence interval, 0.70 to 1.39; difference, -0.2 percentage points; upper boundary of the one-sided 97.5% confidence interval, 2.1 percentage points; P<0.001 for noninferiority). There were no apparent differences between the groups with respect to the incidence of bleeding, acute kidney injury, or procedure-related adverse events.
CONCLUSIONS: Among patients with intermediate coronary-artery lesions undergoing physiological assessment in the cardiac catheterization laboratory, an angiography-guided strategy involving FFRangio was noninferior to a pressure-wire-guided strategy with respect to a composite end point of death, myocardial infarction, or unplanned clinically indicated coronary revascularization at 1 year. (Funded by CathWorks; ALL-RISE ClinicalTrials.gov number, NCT05893498.).
参考来源
- Fearon WF, Jeremias A, Witberg G, et al. Angiography-Derived Fractional Flow Reserve to Guide PCI. N Engl J Med. 2026. PMID: 41910384. doi:10.1056/NEJMoa2600949
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。